The Future of Dravet Syndrome

The medical and scientific environment is changing quickly for Dravet Syndrome, with promising new treatments on the horizon.

In the video below, Dr Andreas Brunklaus, Paediatric Neurologist at the Royal Hospital for Children, Glasgow, looks ahead to the next 5 years and explains why these are exciting and hopeful times for families living with Dravet Syndrome.

Dr Andreas Brunklaus on Future of Dravet Syndrome
Play

This video was filmed in November 2019.

Quotation

"Because Dravet Syndrome is what we call a mono-genetic disorder, this means that Dravet Syndrome is caused by one particular gene change in the SCN1A sodium channel gene and by correcting that particular gene change we would hope that we can really dramatically alter or even cure this disease. I think it’s a real possibility, this has been shown in other neurological mono-genetic disorders. I think this is very exciting for families with children with Dravet Syndrome and I believe that over the next two to five years we might see a real breakthrough.”

Dr Andreas Brunklaus, Paediatric Neurologist at the Royal Hospital for Children, Glasgow

New and Emerging Treatments for Dravet Syndrome

Find out more about the latest treatment developments with a series of video interviews filmed with DSUK, Professor Helen Cross OBE, including the availability of Epidyolex (cannabidiol), the potential future role of fenfluramine and what we might expect from genetic treatments currently under development.

Find Out More

The Role of Genetics and Gene Therapy in Dravet Syndrome

Watch a video with Professor Sameer Zuberi to find out more about the role of genetics in Dravet Syndrome and the latest developments in gene therapy.

Read More